Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis to add 175 jobs in Cambridge, cut elsewhere
Boston Globe, MA
Thu, 11/7/13 - 08:15 am
Tags:
Novartis, Boston, restructuring
Analyst ranks the top 11 pharma giants' prospects, putting GSK on top
Fierce Biotech
Wed, 11/6/13 - 10:39 am
Tags:
GSK, Bayer, Sanofi, Novartis, JNJ, Bristol-Myers Squibb, Merck, AbbVie, Eli Lilly, Pfizer, AstraZeneca
Novartis plots sales cuts in U.K. amid R&D restructuring
Fierce Pharma
Wed, 11/6/13 - 08:27 am
Tags:
UK, R&D, Novartis, layoffs
Novartis chopping 371 research jobs in global R&D shakeup
Fierce Biotech
Tue, 11/5/13 - 11:12 am
Tags:
Novartis, R&D, layoffs
Novartis Said to Mull Animal-Health Sale in Asset Review
Bloomberg
Tue, 11/5/13 - 08:20 am
Tags:
Novartis, animal health
Novartis Faces Criminal Complaint Over Diovan Research In Japan
Pharmalot
Mon, 11/4/13 - 10:04 am
Tags:
Novartis, Diovan, R&D, Japan
Tecfidera Succeeds in Protecting Biogen's MS Market Share From Novartis' Gilenya
Motley Fool
Sun, 11/3/13 - 12:12 pm
Tags:
Gilenya, Novartis, MS, multiple sclerosis, Biogen Idec, Tecfidera
Pfizer Vs. Novartis: A New Era In Breast Cancer Treatment
Seeking Alpha
Thu, 10/31/13 - 09:38 am
Tags:
Pfizer, Novartis, breast cancer, palbociclib, LEE011
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Mon, 10/28/13 - 10:26 am
Tags:
patents, Copaxone, Teva, Nexium, AstraZeneca, Micardis, Boehringer Ingelheim, Sandostatin LAR, Novartis, Exforge, Nasonex, Merck, TriLipix, AbbVie, Evista, Eli Lilly, Restasis, Allergan, Renagel, Sanofi
Novartis' Pharmaceutical Business Faces 2 Major Challenges
Motley Fool
Fri, 10/25/13 - 09:41 am
Tags:
Novartis, Gilenya, Tecfidera, GSK, Seebri Breezhaler, COPD, Xolair
Novartis shares climb after drug maker says it may sell small assets
Marketwatch
Tue, 10/22/13 - 12:49 pm
Tags:
Novartis
Novartis grabs an option to buy biotech startup for up to $300M
Fierce Biotech
Tue, 10/22/13 - 11:43 am
Tags:
M&A, Novartis, SP-420, Sideris Pharmaceuticals
Novartis Raises 2013 Forecast on Lack of Diovan Generic
Bloomberg
Tue, 10/22/13 - 08:11 am
Tags:
Novartis, guidance, Diovan
Novartis advances rival CDK 4/6 cancer drug to Pfizer's palbociclib
Fierce Biotech
Mon, 10/21/13 - 05:55 pm
Tags:
Novartis, cyclin-dependent kinase inhibition [CDK], Pfizer, palbociclib, LEE011
Atchoo! Who’s making money out of flu season
CNBC
Fri, 10/18/13 - 09:34 am
Tags:
Flu, Novartis, GSK, Merck, Sanofi, AstraZeneca
Cleveland Clinic picks top 3 blockbuster drug candidates in the late-stage pipeline
Fierce Biotech
Thu, 10/17/13 - 06:18 pm
Tags:
Cleveland Clinic, JNJ, Pharmacyclics, Novartis, serelaxin, ibrutinib, sofosbuvir, Gilead
3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
Motley Fool
Thu, 10/17/13 - 08:24 am
Tags:
Parkinson's Disease, pimavanserin, Acadia, Duodopa, AbbVie, LCIG, AFQ056, Novartis
Top 10 Drugmakers in Emerging Markets
Fierce Pharma
Mon, 10/14/13 - 10:31 am
Tags:
emerging markets, Bayer, Sanofi, Merck KGaA, GSK, Novartis, JNJ, Novo Nordisk, AstraZeneca, Pfizer, Roche
The Big Bucks in Keeping Kids Focused
Bloomberg/Businessweek
Fri, 10/11/13 - 08:50 am
Tags:
ADHD, Shire, Vyvanse, Novartis, JNJ, Europe
Novartis - Make Money From COPD Opportunity
Seeking Alpha
Tue, 10/8/13 - 05:06 pm
Tags:
COPD, Novartis, GSK, Theravance, Pfizer, Ultibro Breezhaler

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.